<http://schema.org/description>
"Merck KGaA entered into an exclusive license agreement with Symphogen A/S for the development and commercialization of oncology candidate, Sym004."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/82707/merck-kgaa-boosts-oncology-pipeline>